Skip to main content
OpenTrials
Completed

NCT Number: NCT06655688

Acceptance and Commitment Therapy (ACT) for Family Members After a First Psychotic Attack

This study aimed to evaluate the effect of ACT administered online to family members on self-stigmatization, coping with stress, and psychological resilience levels after the first psychotic attack (FPA).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Saglik Bilimleri Universitesi

Istanbul, 34668, Turkey (Türkiye)

About this study

This study is a pretest, posttest, follow-up, randomized controlled experimental study. This study will be conducted with family members of individuals diagnosed with FPA who come to the psychiatry outpatient clinic of a training and research hospital. According to the results of G-power analysis, the minimum sample size of the study was calculated as 32 (intervention 16, control 16). Personal Information Form will be applied to the individuals before randomization. The computer-aided https://www.random.org/integers/ program will be used to assign the intervention and control groups without bias. It is planned that the intervention group will consist of 8-12 participants and the program will be implemented as two intervention groups. The Acceptance and Commitment Therapy (ACT) Based Intervention Program will be implemented online in eight sessions. Each session will last 60-90 minutes on average. Two sessions will be held for one group per week. The control group will not receive any intervention from the researcher. The intervention groups will be followed up with a post-test after the program is completed and three months later, while the control group will be followed up with a post-test four weeks and three months later.

In the preparation of the interventions and planning of the sessions based on ACT, the researcher utilized studies in the literature and the basic ACT training she had received. The sessions were prepared based on six components of psychological flexibility found at the basis of ACT.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Acceptance to participate in the research,
  • Being responsible for the care of an individual who has been diagnosed with schizophrenia and other psychotic disorders according to DSM-5 diagnostic criteria at least six months ago and at most five years ago,
  • Living with the patient for at least one year,
  • First-degree relatives (mother, father, siblings, adult children and spouse),
  • The home environment is suitable for online interviewing (having a computer/smartphone, internet at home, the patient can be alone in the room during the session, etc.),
  • Being literate,
  • Communication is not a problem.

Exclusion criteria

  • Refusal to participate in the research,
  • Responsible for the care of an individual diagnosed with schizophrenia and other psychotic disorders for less than six months or more than five years according to DSM-V diagnostic criteria,
  • Living with the patient for less than one year,
  • No first-degree relatives (mother, father, siblings, adult children and spouse),
  • The home environment is not suitable for online counseling (having a computer/smartphone, internet at home, the patient can be alone in the room during the session, etc.),
  • Illiteracy,
  • Communication problems.

Treatment and study plan

Acceptance and Commitment Therapy

Behavioral

Acceptance and Commitment Therapy Based Intervention Program was applied to the intervention group in eight sessions online. Each session will last an average of 60-90 minutes. There will be two sessions for one group per week.

Primary outcomes

  1. Self-Stigma Inventory for Families (SSI-F)

    Time frame: 6 month

    The scale was developed to assess the self-stigmatization of family members of individuals diagnosed with schizophrenia. The scores that can be obtained from the scale, which includes 3 factors and 14 items in total, including internalized stereotypes and withdrawal from society, concealment of the disease and perceived worthlessness, vary between 14-70. A high score indicates a high level of self-stigmatization of the family member.

Secondary outcomes

  1. Stress Coping Scale

    Time frame: 6 month

    The scale consists of 23 items and is a 5-point Likert type. It includes 3 sub-dimensions: seeking social support, problem-focused coping and avoidance-focused coping. Items 10, 17 and 20 of the scale are reverse-scored. The total score and subscale scores obtained from the scale provide information about individuals' coping strategies with stress. The scale gives scores ranging from 23 to 115 reflecting the general level of coping strategies used by individuals to cope with stress. High scores obtained from the scale and its subscales indicate an increased tendency to use relevant coping mechanisms.

  2. Brief Resilience Scale

    Time frame: 6 month

    The scale was developed to measure the psychological resilience of individuals. This scale, which consists of 6 items in 5-point Likert type, is a self-report measurement tool. It is scored between "not at all appropriate" (1) and "completely appropriate" (5). Items 2, 4 and 6 of these 6 items are reverse coded. High scores indicate a high level of psychological resilience and low scores indicate a low level of psychological resilience.

Sponsors and collaborators

Lead sponsor

Saglik Bilimleri Universitesi

Other

Registry information

Official study title

The Effect of Acceptance and Commitment Therapy on Self-Stigmatization, Coping With Stress and Psychological Resilience Levels of Family Members After First Psychotic Attack Diagnosis

Important dates

Study start
2024
Primary completion
2024
Study completion
2025
First posted
Oct 23, 2024
Registry last updated
May 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.